Spermosens Investor Relations Material
Latest events
Q1 2025
7 May, 2025
Q4 2024
13 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Spermosens
Access all reports
Spermosens AB is a Sweden-based medical technology company focused on fertility diagnostics. The company develops innovative solutions aimed at improving the understanding and treatment of male infertility. Spermosens’ technology centers on analyzing sperm function and compatibility with the egg, providing valuable insights for assisted reproductive treatments such as in vitro fertilization (IVF). The company is headquartered in Lund, Sweden, and its shares are listed on the Spotlight Stock Market.
)
)
)